In the last three years, the Food and Drug Administration has approved rebranded versions of Mounjaro and Ozempic for weight loss, leading demand to skyrocket
Anecdotally, health systems have closed hospital-based metabolic bariatric surgery programs due to decreased demand, but empirical data on the association of increased prescribing of GLP-1 [receptor agonists] with use of metabolic bariatric surgery is unavailable, to our knowledge, Kevin Lin, BA, from Harvard Medical School, and colleagues wrote in JAMA Network Open
Who is eligible for liraglutide
telehealth prescriptions may not be covered even if in-office GLP-1 is
* While weight loss can be challenging, working with a healthcare provider or diabetes educator to develop a plan can help you reach your body weight goals
This may allow KPV to enter intestinal epithelial and immune cells, where it can influence inflammatory signaling from within the cell